Study database and blood samples for colon cancer cachexia
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study collects clinical information and planned blood samples to better understand “cachexia,” which is a serious wasting condition that can happen with advanced cancer. It may help doctors find better ways to predict and manage symptoms in people with colon cancer who can’t have surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older
- Your colon cancer care is at the Institut du Cancer de Montpellier (Val d’Aurelle)
- Your colon cancer cannot be treated with surgery right now (for the main tumor or spread)
- You need colon cancer treatment now or soon (like chemotherapy or targeted therapy)
- You agree to the study rules and planned blood samples, and sign the consent form
- You’re covered by France’s social protection system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tissue, blood, and imaging samples from people having surgery for colon cancer or related liver tumors, to learn more about the disease and potentially improve future treatments.
This study looks at how the immune system reacts to colorectal cancer in the body. It aims to understand immune responses better, which may help improve future treatments.
This study collects clinical and lab information from people who have surgery for colon cancer (or certain precancer growths) and related spread to organs. It may help researchers better understand colon cancer and improve future care, but it is not a new medication trial.
This study builds a clinical and biological database for people newly diagnosed with certain cancers. It may help doctors better understand cancer patterns and improve future care, and it involves agreeing to extra blood samples.
This study collects clinical and lab information to better understand metastatic cancers of the digestive system and how patients respond to treatment. It may help improve future care, but it is mainly focused on collecting data rather than testing a new drug.
This study collects medical information and small tissue or fluid samples from people with peritoneal (abdominal lining) cancer. It aims to better understand the disease and improve future care plans.
Hear when a new Colon Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.